|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute interstitial pneumonia: radiographic and CT findings in nine patients 显示文摘 | Primack S L Hartman T E Ikezoe J | 1993 | Radiology1993，188，3： | 1 |
| 2 | Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development显示文摘 | SCHWAB K R PATTERSON L T HARTMAN H A | 2007 | BMC Biol2007，5，： | 1 |
| 3 | High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex显示文摘 | COSTELLO L C HARTMAN T E RYU J H | 2000 | Mayo Clin Proc2000，75，6： | 1 |
| 4 | Soures of resistance to soybean rust in perennial Glycine species 显示文摘 | Hartman G L Wang T C Hymowitz T | 1992 | Plant Disease1992，76，4： | 1 |
| 5 | Cessation of renal morphogenesis in mice 显示文摘 | Hartman H A Lai H L Patterson L T | 2007 | Dev Biol2007，310，2： | 1 |
| 6 | In vitro antibiotic sensitivity of strains of Omithobacterium rhinotracheale isolated in The Netherlands betweer 1996 and 1999显示文摘 | van Veen L Hartman E Fabri T | 2001 | Vet Rec2001，149，20： | 1 |
| 7 | Budesonide/formoterol added to tiotropium is well tolerated and reduces risk of severe exacerbations in COPD patients显示文摘 | Welte T Hartman L Polanowski T | 2009 | Am J Respir Crit Care Med2009，179，4： | 1 |
| 8 | Dietary saturated fat intake is inversely associated with bone density in humans:analysis of NHANES III显示文摘 | CORWIN R L HARTMAN T J MACZUGA S A | 2006 | J Nutr2006，136，1： | 1 |
| 9 | Physical map location of the Rps1-kallele in soybean显示文摘 | GARNER M E HYMOWITZ T XU S J HARTMAN G L | 2001 | Crop Sci2001，41，： | 1 |
| 10 | Reboiler and Condenser Operating Problems显示文摘 | HARTMAN E L BARLETTA T | 2003 | ptq2003，，2： | 1 |
| 11 | Ebola and Marburg hemorrhagic fever显示文摘 | Hartman A L Towner J S Nichol S T | 2010 | Clin Lab Med2010，30，1： | 1 |
| 12 | py- gol and pygo2 roles in Wnt signaling in mammalian kidney development显示文摘 | SCHWAB K R PATFERSON L T HARTMAN H A et ol | 2007 | BMC Biology2007，，5： | 1 |
| 13 | Chaotic response in electric arc furnaces显示文摘 | King P E Ochs T L Hartman A D | 1994 | Journal Applied Physics1994，76，4： | 1 |
| 14 | ln vitro antibiotic sensitivity of strains of Ornithobacterium rhinotracheale isolated in The Netherlands between 1996 and 1999显示文摘 | van Veen L Hartman E Fabri T | 2001 | Vet Rec2001，149，20： | 1 |
| 15 | Introducing WATERS: a workflow for the alignment, taxonomy, and ecology of ribosomal sequences 显示文摘 | Hartman A L Riddle S McPhillips T | 2010 | BMC bioinformatics2010，11，1： | 1 |
| 16 | Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers显示文摘 | Colbert L H Hartman T J Malila N | 2001 | Cancer Epidemiol Biomarkers Prev2001，10，3： | 1 |
| 17 | Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs. | Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch | 2017 | World Journal of Virology2017，6，4： | 1 |
| 18 | Creating Interactive Online Instruction:The McGoogan Library Experience显示文摘 | Hartman T L Fial A V | 2015 | Medical Reference Services Quarterly2015，34，4： | 1 |
| 19 | A rapid method for the regional dissection of the rat brain 显示文摘 | Heffner T G Hartman J A Seiden L S | 1980 | Pharmacol Biochem Behav1980，13，3： | 1 |
| 20 | Benign breast diseast disease and the risk of breast cancer显示文摘 | Hartman L C Sellers T A Frost M H | 2005 | N Engl J Med2005，353，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员